Clinical Trials Browser

Phase 1 × Interventional × Positron-Emission Tomography × Clear all

NCT03535545 2026-02-27

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

Phase 1 Recruiting

Lung Neoplasms, Pulmonary Fibrosis

NCT07436858 2026-02-27

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05035407 2025-12-02

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

Phase 1 Terminated

36 enrolled 7 charts

Carcinoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT04017819 2025-11-05

Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4

Phase 1 Suspended

Lung Neoplasms, Neoplasms

NCT05737615 2025-09-04

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT03054792 2024-12-13

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

Phase 1 Enrolling by invitation

Rhabdomyosarcoma, Sarcoma

NCT02809690 2023-09-07

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms

NCT02717572 2019-04-05

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT02297386 2018-08-06

[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT02708511 2018-04-05

Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer

Phase 1 Terminated

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT01207895 2017-02-23

Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer

Phase 1 Completed

Gastrointestinal

Rectal Neoplasms

NCT02112162 2016-12-08

Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery

Phase 1 Terminated

Gastrointestinal

Rectal Neoplasms

NCT02437539 2015-08-24

uPAR-PET

Phase 1 Completed

BreastGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Prostatic Neoplasms